TY - JOUR
T1 - Participant-partners in genetic research
T2 - an exome study with families of children with unexplained medical conditions
AU - Katsanis, Sara Huston
AU - Minear, Mollie A.
AU - Sadeghpour, Azita
AU - Cope, Heidi
AU - Perilla, Yezmin
AU - Cook-Deegan, Robert
AU - Genomics, Duke Task Force For Neonatal
AU - Katsanis, Nicholas
AU - Davis, Erica E.
AU - Angrist, Misha
N1 - Funding Information:
We thank the families for their excitement for and engagement in this study. We also thank the Duke Task Force for Neonatal Genomics team and the Center for Human Disease Modeling for leading the clinical and basic research that made this study possible. This work was supported in part by grant NIH P50DK096415-01. MA, BCD and MAM were supported by NIH 5P50-HG003391-07. NK is a Distinguished Brumley Professor. MAM is currently serving as AAAS Science & Technology Policy Fellow at the National Institutes of Health (NIH). She is contributing to this article in her personal capacity based on research conducted while employed at Duke University. The views expressed in this commentary are her own and do not necessarily reflect any official views held by the NIH, the Department of Health and Human Services, or the US government.
Publisher Copyright:
©Sara Huston Katsanis, Mollie A Minear, Azita Sadeghpour, Heidi Cope, Yezmin Perilla, Robert Cook-Deegan, Duke Task Force For Neonatal Genomics, Nicholas Katsanis, Erica E Davis, Misha Angrist.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Background: Unlike aggregate research on groups of participants with a particular disorder, genomic research on discrete families’ rare conditions could result in data of use to families, their healthcare, as well as generating knowledge on the human genome. Objective: In a study of families seeking to rule in/out genetic causes for their children’s medical conditions via exome sequencing, we solicited their views on the importance of genomic information. Our aim was to learn the interests of parents in seeking genomic research data and to gauge their responsiveness and engagement with the research team. Methods: At enrollment, we offered participants options in the consent form for receiving potentially clinically relevant research results. We also offered an option of being a “partner” versus a “traditional” participant; partners could be re-contacted for research and study activities. We invited adult partners to complete a pre-exome survey, attend annual family forums, and participate in other inter-family interaction opportunities. Results: Of the 385 adults enrolled, 79% opted for “partnership” with the research team. Nearly all (99.2%) participants opted to receive research results pertaining to their children’s primary conditions. A majority indicated the desire to receive additional clinically relevant outside the scope of their children’s conditions (92.7%) and an interest in non-clinically relevant genetic information (82.7%). Conclusions: Most participants chose partnership, including its rights and potential burdens; however, active engagement in study activities remained the exception. Not surprisingly, the overwhelming majority of participants—both partners and traditional—expected to receive all genetic information resulting from the research study.
AB - Background: Unlike aggregate research on groups of participants with a particular disorder, genomic research on discrete families’ rare conditions could result in data of use to families, their healthcare, as well as generating knowledge on the human genome. Objective: In a study of families seeking to rule in/out genetic causes for their children’s medical conditions via exome sequencing, we solicited their views on the importance of genomic information. Our aim was to learn the interests of parents in seeking genomic research data and to gauge their responsiveness and engagement with the research team. Methods: At enrollment, we offered participants options in the consent form for receiving potentially clinically relevant research results. We also offered an option of being a “partner” versus a “traditional” participant; partners could be re-contacted for research and study activities. We invited adult partners to complete a pre-exome survey, attend annual family forums, and participate in other inter-family interaction opportunities. Results: Of the 385 adults enrolled, 79% opted for “partnership” with the research team. Nearly all (99.2%) participants opted to receive research results pertaining to their children’s primary conditions. A majority indicated the desire to receive additional clinically relevant outside the scope of their children’s conditions (92.7%) and an interest in non-clinically relevant genetic information (82.7%). Conclusions: Most participants chose partnership, including its rights and potential burdens; however, active engagement in study activities remained the exception. Not surprisingly, the overwhelming majority of participants—both partners and traditional—expected to receive all genetic information resulting from the research study.
KW - Exome sequencing
KW - Genome sequencing
KW - Participant engagement
KW - Partnership
KW - Return of results
UR - http://www.scopus.com/inward/record.url?scp=85076642211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076642211&partnerID=8YFLogxK
U2 - 10.2196/jopm.8958
DO - 10.2196/jopm.8958
M3 - Article
C2 - 33052113
AN - SCOPUS:85076642211
SN - 2152-7202
VL - 10
JO - Journal of Participatory Medicine
JF - Journal of Participatory Medicine
IS - 1
M1 - e2
ER -